FDA Inspection 1110384 — B & B Pharmaceuticals, Inc.

B & B Pharmaceuticals, Inc. — FEI 3000719772

The FDA completed an inspection of B & B Pharmaceuticals, Inc. on Nov 18, 2019 in Englewood, CO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 18, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Englewood, CO (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.